Soligenix, Inc. (NASDAQ:SNGX) is a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, such as Cutaneous T-Cell Lymphoma and Pediatric Crohn’s disease. emagine partnered with Soligenix to modernize their web presence and effectively feature their important research.
View the website here: https://www.soligenix.com/
We trusted emagine’s recommendations and we appreciated that their creative and UX experts pushed back on some of our ideas that they felt might compromise our goals for the project. We’re very proud of the outcome.Christopher J. Schaber, Ph.D., President & CEO, Soligenix
The site architecture makes all scientific research easy to find for all visitors to the site. Our UX approach examined the types of the content Soligenix needed to display and made recommendations of where it should live, so all users could find the type of content they needed – from patients to pharmaceutical researchers. All resources and scientific papers were given a home on the site that complimented the main content and allowed for further reading for scientific visitors.
The new design of the site drove the project to successful launch. From the harmonious use of brand colors, to the dynamic animation in the masthead and pipelines, we created a pleasing experience that made the materials easy and interesting to read. Design also drove the content writing and helped organize their content into easy-to-find places
The SEO strategists at emagine worked with the Soligenix team for the entirety of the project to set up the new Soligenix website for success. The strategists advised on keyword research, recommended URLs, and optimized content to perform as ideally as possible for ranking on search engine results.